Papagrigoriadis S, Papadopoulou P, Kolias V, Panagiotidis H, Loizou M
Second Department of Surgery, General Hospital of Athens, Holargos, Greece.
Eur J Surg. 1998 Sep;164(9):693-6. doi: 10.1080/110241598750005589.
To present our experience of leiomyosarcoma of the gastrointestinal tract during a 10 year period and review similar publications.
Retrospective study.
Teaching hospital, Greece.
14 patients who were treated for leiomyosarcoma between 1983 and 1993.
Tumours were diagnosed by endoscopy, computed tomography, and contrast examination. All patients were treated by resection and no adjuvant treatment was given.
Morbidity, mortality, and outcome.
The diagnosis was made preoperatively in 10/14 patients: 4 of the tumours were locally advanced at the time of laparotomy, and two had liver metastases. Resection was potentially curative (all macroscopic tumour removed) in 12 patients (86%). Three patients died of recurrent disease at 5, 8 and 63 months, respectively. The mean follow up in the 11 survivors was 44 months (range 24-83).
Resection is the treatment of choice for these tumours. A multicentre trial would be required to assess the effect of adjuvant chemotherapy.
介绍我们在10年期间治疗胃肠道平滑肌肉瘤的经验,并回顾类似的出版物。
回顾性研究。
希腊的教学医院。
1983年至1993年间接受平滑肌肉瘤治疗的14例患者。
通过内镜检查、计算机断层扫描和造影检查诊断肿瘤。所有患者均接受手术切除,未给予辅助治疗。
发病率、死亡率和预后。
14例患者中有10例在术前确诊:4例肿瘤在剖腹手术时局部晚期,2例有肝转移。12例患者(86%)手术切除可能治愈(所有肉眼可见肿瘤均被切除)。3例患者分别在5个月、8个月和63个月死于复发性疾病。11例幸存者的平均随访时间为44个月(范围24 - 83个月)。
手术切除是这些肿瘤的首选治疗方法。需要进行多中心试验来评估辅助化疗的效果。